Stay updated with breaking news from World Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ROCKLAND, Mass.--(BUSINESS WIRE)--Jan 22, 2024--
Merck a leading science and technology company today announced new realworld data that continue to reinforce the JAVELIN Bladder regimen of firstline platinumbased chemotherapy followed by BAVENCIO avelumab maintenance as a standard of care for eligible patients with locally advanced or metastatic urothelial carcinoma UC who do not progress on firstline chemotherapy.
“When you’re smiling, the whole world smiles with you” so went the old song popularised by Frank Sinatra, Nat King Cole, and Louis Armstrong.
Drs. Dorff and McKay discuss real-world data from DEAR trial comparing darolutamide, enzalutamide and apalutamide, providing clinical pearls on their experiences to optimize outcomes.
Ten abstracts, including three oral presentations, spotlight the expanding body of evidence supporting odronextamab in follicular lymphoma and diffuse...